Citation Impact
Citing Papers
Nosocomial Human Parovirus B19 Infection: Lack of Transmission From a Chronically Infected Patient to Hospital Staff
1992
Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program
2007 StandoutNobel
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
The transfusion-associated transmission of parvovirus B19
1999
Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.
1996
Fertility and adjuvant treatment in young women with breast cancer
2007
Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: Use of intravenous immunoglobulin?A report of eight patients
1999
Novel cytomorphology of the giant proerythroblasts of parvovirus B19 infection
1998
Reconstituted Immunity against Persistent Parvovirus B19 Infection in a Patient with Acquired Immunodeficiency Syndrome after Highly Active Antiretroviral Therapy
2001
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Management of persistent B19 parvovirus infection in AIDS
1995
Pathogenesis of human parvovirus B19 in rheumatic disease
2000
Replication and cytopathaology of human parvovirus B19 in human umbilical cord blood erythroid progenitor cells
1992
Parvovirus B19 In HIV infection: A treatable cause of anemia
1996
New approaches to antibody therapy
2000
Kaposi's sarcoma
1993
Parvovirus B19: implications for transfusion medicine. Summary of a workshop
2001
Vascular targeting—a new approach to the therapy of solid tumors
1994
Parvovirus B19 infection and bone marrow transplantation
1992
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
1996 Standout
2 B19 parvovirus
1995
Human parvovirus B19 infection in bone marrow transplantation patients
1993
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
1992 StandoutNature
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.
1992
Reshaping human antibodies for therapy
1988 StandoutNatureNobel
Transfusion Medicine — Blood Transfusion
1999 Standout
Pure Red-Cell Aplasia Due to Parvovirus B19 Infection in a Patient with AIDS-related Complex
1992
PARVOVIRUS B19 INFECTION IN PEDIATRIC TRANSPLANT PATIENTS
1993
A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma
2002
Persistent B19 parvovirus infection in pediatric malignancies
1998
Ovarian function and childbearing issues in breast cancer survivors
2007
Acute parvovirus B19 infection mimicking myelodysplastic syndrome of the bone marrow
1992
The use of combinations of monoclonal antibodies in clinical oncology
2015
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Chemical remodelling of cell surfaces in living animals
2004 StandoutNatureNobel
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
Cancer-associated carbohydrates identified by monoclonal antibodies
1990
Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy
2001
Metabolic Labeling of Sialic Acids in Living Animals with Alkynyl Sugars
2009 StandoutNobel
Air pollution and health
2002 Standout
Quantitative Analysis of Neutralizing Immune Responses to Human Parvovirus B19 Using a Novel Reverse Transcriptase–Polymerase Chain Reaction–Based Assay
1999
Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides
1997
Acute myocardial infarction in young adults who abuse amphetamines
2008
Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum
1991
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Evaluation of Patients With Methamphetamine- and Cocaine-Related Chest Pain in a Chest Pain Observation Unit
2007
Parvovirus B19 infection: association with third‐trimester intrauterine fetal death
2000
Clinical Relevance of Parvovirus B19 as a Cause of Anemia in Patients with Human Immunodeficiency Virus Infection
1997
Resistance to Parvovirus B19 Infection Due to Lack of Virus Receptor (Erythrocyte P Antigen)
1994
Chemotherapy for Malignant Pleural Mesothelioma
2003
Fibromyalgia and Parvovirus Infection
1991
Persistent parvovirus B19 related anemia of seven years' duration in an HIV-infected patient: Complete remission associated with highly active antiretroviral therapy
1999
Human parvoviruses: implications for transfusion medicine
1994
Identification of a novel simian parvovirus in cynomolgus monkeys with severe anemia. A paradigm of human B19 parvovirus infection.
1994
Sequence variability among different parvovirus B19 isolates
1996
Albumin batches and B19 parvovirus DNA
1995
Transient Aplastic Crisis in Patients With Sickle Cell Disease
1992
Thrombotic Microangiopathy Associated with Parvovirus B 19 Infection after Renal Transplantation
2000
Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA
1993
Parvovirus B19 for the hematologist
1992
Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
1988 Standout
Kaposi's Sarcoma
2000 Standout
Parvovirus B19 as a cause of acquired chronic pure red cell aplasia
1994
Parvovirus B19
2004 Standout
Extended Work Shifts and the Risk of Motor Vehicle Crashes among Interns
2005 Standout
Preservation of Fertility in Patients with Cancer
2009 Standout
Advances in Malignant Mesothelioma
2005 Standout
Candidate Recombinant Vaccine for Human B19 Parvovirus
1993
Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients
2000
Management of Cocaine-Associated Chest Pain and Myocardial Infarction
2008
Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient
1993
Molecular Recognition of a Salmonella Trisaccharide Epitope by Monoclonal Antibody Se155-4
1994 StandoutNobel
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
1996 Standout
Infection with parvovirus B19
1999
Experimental infection of cynomolgus monkeys with simian parvovirus
1997
Nosocomial Human Parvovirus B19 Infection: Lack of Transmission from a Chronically Infected Patient to Hospital Staff
1992
Anti-retroviral therapy of human immunodeficiency virus infection: current strategies and challenges for the future [published erratum appears in Blood 1991 Dec 15;78(12):3330]
1991
Cisplatin and Gemcitabine Treatment for Malignant Mesothelioma: A Phase II Study
1999
The CD8+ Dendritic Cell Subset Selectively Endocytoses Dying Cells in Culture and In Vivo
2002 StandoutNobel
Cardiovascular Effects of Cocaine
2010
Paclitaxel Is Safe and Effective in the Treatment of Advanced AIDS-Related Kaposi's Sarcoma
1999
Recognition of a Cell-Surface Oligosaccharide of Pathogenic Salmonella by an Antibody Fab Fragment
1991 Science
Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell–mediated immunity via dendritic cells
2007 StandoutNobel
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia
1995
Successful replication of parvovirus B19 in the human megakaryocytic leukemia cell line MB-02
1993
Alpha interferon therapy of AIDS-associated Kaposi's sarcoma.
1986
Acquired immunodeficiency syndrome-related lymphoma [see comments]
1992
Exploiting Differences in Sialoside Expression for Selective Targeting of MRI Contrast Reagents
1999 StandoutNobel
Integrins: Versatility, modulation, and signaling in cell adhesion
1992 Standout
Expansion of natural killer cells but not T cells in human interleukin 2/interleukin 2 receptor (Tac) transgenic mice.
1989 StandoutNobel
Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial
1991
Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins.
1989
Human Parvovirus B19
2002 Standout
A Strategy for the Selective Imaging of Glycans Using Caged Metabolic Precursors
2010 StandoutNobel
High-Dose Recombinant Interleukin 2 in the Treatment of Patients With Disseminated Cancer
1986
Pure red blood cell aplasia associated with parvovirus B19 infection in large granular lymphocyte leukemia [letter]
1996
Antitumor Monoclonal Antibodies Enhance Cross-Presentation of Cellular Antigens and the Generation of Myeloma-specific Killer T Cells by Dendritic Cells
2002
Acquired immunodeficiency syndrome-related lymphoma [see comments]
1992
Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.
1989
A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response
1991
Should We Use a Case-Crossover Design?
2000
PARVOVIRUS B19 INFECTION CAUSING PURE RED CELL APLASIA IN A RECIPIENT OF PEDIATRIC DONOR KIDNEYS1
1993
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
1987 Standout
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions
1993
Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood
1992
Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice
2006 StandoutNobel
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
1989 StandoutScience
Dendritic cell maturation by innate lymphocytes
2005 StandoutNobel
Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin.
1986
Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance
2002 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Generation of Neutralizing Human Monoclonal Antibodies against Parvovirus B19 Proteins
1999
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Severe Leukopenia and Dysregulated Erythropoiesis in SCID Mice Persistently Infected with the Parvovirus Minute Virus of Mice
1999
Epidemiologic evidence of cardiovascular effects of particulate air pollution.
2001
Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.
1987
RHEUMATIC MANIFESTATIONS OF PARVOVIRUS B19 INFECTION
1998
Inhibitors of human immunodeficiency virus integrase.
1993 StandoutNobel
Tolerogenic Dendritic Cells
2003 StandoutNobel
Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
2000 StandoutNobel
Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon
1989
Improvement of Anemia Induced by Parvovirus B19 in a Patient With AIDS After Combined Antiretroviral Therapy
2000
Biological therapy of cancer
1986
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Lymphoproliferative responses after infection with human parvovirus B19
1996
Improvement of Anemia Induced by Parvovirus B19 in a Patient With AIDS After Combined Antiretroviral Therapy
2000
Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.
1989 StandoutNobel
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
2005 StandoutNobel
Erythrocyte P Antigen: Cellular Receptor for B19 Parvovirus
1993 StandoutScience
Clinical Translation of Nanomedicine
2015
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
Increased Particulate Air Pollution and the Triggering of Myocardial Infarction
2001 Standout
Engineering Chemical Reactivity on Cell Surfaces Through Oligosaccharide Biosynthesis
1997 StandoutScienceNobel
Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells
2003
A monoclonal antibody with binding and inhibiting activity towards human pancreatic carcinoma cells
1986
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of David M. Mintzer being referenced
Peripheral T-cell lymphoma in a patient with the acquired immunodeficiency syndrome
1988
Persistent B19 Parvovirus Infection in Patients Infected with Human Immunodeficiency Virus Type 1 (HIV-1): A Treatable Cause of Anemia in AIDS
1990
Chemotherapy-Induced Amenorrhea from Adjuvant Breast Cancer Treatment: The Effect of the Addition of Taxanes
2005
Phase II Multicenter Trial of Albumin-Bound Paclitaxel and Capecitabine in First-Line Treatment of Patients With Metastatic Breast Cancer
2011
A Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab with or Without Bevacizumab as Frontline Therapy for Metastatic Colorectal Cancer. A Fox Chase Extramural Research Study
2012
Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites.
1988
Treatment of Kaposi's Sarcoma and Thrombocytopenia with Vincristine in Patients with the Acquired Immunodeficiency Syndrome
1985
Triggering of Myocardial Infarction by Cocaine
1999
Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.
1985
Phase II trial of high-dose cisplatin in patients with malignant mesothelioma.
1985